中金:维持亚盛医药(06855.HK)跑赢行业评级 目标价45港元

智通财经
Aug 26
【中金:维持亚盛医药(06855.HK)跑赢行业评级 目标价45港元】智通财经APP获悉,中金发布研报称,考虑到公司加快核心全球临床入组带来的研发费用,予目标价45港元,较当前股价有35.2%的上行空间。考虑到公司推进全球研发的长期价值,该行维持跑赢行业评级不变。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10